Alfacalcidol

5 trials 2 recruiting AGastroenterology

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

2 Recruiting

0 Completed trials

5 Sponsors

11 Countries

Phase III

Phase IV

Phase III: 3 Phase IV: 2

Indications tested

Hypoparathyroidism 2

Sponsors using this IMP

Academisch Ziekenhuis Leiden 1 Alexion Pharmaceuticals Inc. 1 Amolyt Pharma 1 Calcilytix Therapeutics Inc. 1 Region Midtjylland 1

All trials

5 total

Evaluation of the efficacy and safety of eneboparatide (AZP-3601) in patients with chronic hypoparathyroidism (CALYPSO) Not authorised

2022-503126-12-00 Phase III 1 country Amolyt Pharma
Active vitamin D for secondary hyperparathyroidism after bariatric surgery: a multicenter randomized controlled trial (ActiVitD) Pending

2023-510312-40-00 Phase IV 1 country Academisch Ziekenhuis Leiden
Impact of treatment with TransCon PTH on Quality of Life, cognitive function, brain structure, and cerebral capillary bloodflow in patients … Pending

2025-523930-14-00 Phase IV 1 country Region Midtjylland
Evaluation of the efficacy and safety of eneboparatide (AZP-3601) in patients with chronic hypoparathyroidism (CALYPSO) Recruiting

2022-503126-12-01 Phase III 10 countries Alexion Pharmaceuticals Inc.
Clinical study to investigate the Efficacy and Safety of Encaleret Compared to Standard of Care treatment in patients with Autosomal Dominan… Recruiting

2022-501398-38-00 Phase III 6 countries Calcilytix Therapeutics Inc.

Showing 1–5 of 5 trials

← All drugs A–Z